X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
0
https://www.fiercepharma.com/pharma/gilead-had-its-best-growth-year-2015-truly-believes-veklury-despite-sinking-sales
https://endpts.com/gilead-quashes-microcap-biotechs-matinas-hope-of-partnering-on-oral-covid-19-drug/
https://www.gilead.com/news-and-press/press-room/press-releases/2022/9/who-expands-recommendation-for-veklury-remdesivir-to-patients-with-severe-disease-in-latest-update-to-covid19-guideline
https://endpts.com/study-identifies-covid-19-patients-with-mutations-indicating-remdesivir-resistance/
https://nyulangone.org/news/remdesivir-resistant-version-covid-19-detected-organ-transplant-recipients
https://www.nasdaq.com/articles/who-recommends-gileads-gild-veklury-for-severe-covid-19
https://www.pharmaceutical-technology.com/news/gilead-veklury-who-recommendation/
https://www.europeanpharmaceuticalreview.com/news/173574/trio-of-therapies-reduces-risk-of-death-in-patients-with-severe-covid-19/
https://www.pharmaceutical-technology.com/news/gilead-revenue-q2-2022/
https://www.fiercebiotech.com/biotech/activ-nrx-tanks-peptide-fails-nih-trial-severe-covid-19-patients
https://www.fiercepharma.com/pharma/fda-converts-eua-lillys-olumiant-full-nod-hospitalized-covid-19-patients
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-approves-first-covid-19-treatment-young-children
https://health.economictimes.indiatimes.com/news/pharma/gileads-remdesivir-fails-to-show-benefit-in-european-trial-no-fetus-risk-seen-with-first-trimester-vaccination/90656333
https://endpts.com/fda-updates-mercks-covid-19-pill-eua-and-reaffirms-it-should-only-be-used-as-a-last-resort/
https://www.news-medical.net/news/20220214/Researchers-identify-a-powerful-combination-of-antivirals-to-treat-COVID-19.aspx
https://www.clinicaltrialsarena.com/news/gilead-veklury-variants-studies/
https://www.prnewswire.com/news-releases/redhill-biopharmas-oral-opaganib-reduces-mortality-by-70-given-on-top-of-remdesivir-and-corticosteroids-in-severe-covid-19-301476549.html
https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/study-reveals-hyperimmune-intravenous-immunoglobulin-doesnt-help-covid-19-patients/articleshow/89173902.cms
https://www.pharmaceutical-technology.com/news/gilead-veklury-fda-approval-covid-19-outpatients/
https://www.reuters.com/article/us-health-coronavirus-fda-remdesivir/fda-expands-use-of-remdesivir-to-patients-with-high-risk-of-hospitalization-idUSKBN2JV2A7
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-5-2022-1641361383.pdf
https://pressroom.today/2022/01/28/how-pharma-giants-are-investing-heavily-in-rd-to-develop-patient-friendly-drugs-parmjit-arora-health-biotech/amp/
http://www.pharmafile.com/news/600878/veklury-demonstrates-reduced-risk-hospitalisation-high-risk-patients-covid-19
http://www.pharmafile.com/news/600878/veklury-demonstrates-reduced-risk-hospitalisation-high-risk-patients-covid-19
https://www.gilead.com/news-and-press/press-room/press-releases/2021/12/gilead-announces-new-england-journal-of-medicine-publication-of-data-demonstrating-veklury-remdesivir-significantly-reduced-risk-of-hospitalization
https://www.clinicaltrialsarena.com/news/nrx-encouraging-safety-zyesami-trial/
https://www.fiercepharma.com/manufacturing/gilead-recalls-two-lots-covid-19-drug-veklury-after-investigation-confirms-glass
https://www.dailymail.co.uk/news/article-10273903/Gilead-recalling-two-lots-remdesivir-complaint-glass-particles-vials.html
https://www.pharmacompass.com/pdf/news/gilead-issues-a-voluntary-nationwide-recall-of-two-lots-of-veklury-remdesivir-1638854460.pdf
https://www.globenewswire.com/news-release/2021/11/29/2341962/0/en/NRx-Pharmaceuticals-Identifies-Significantly-Higher-Likelihood-of-Surviving-and-Recovering-from-Critical-COVID-19-in-ZYESAMI-aviptadil-Treated-Patients-Previously-Administered-Remd.html
https://www.raps.org/news-and-articles/news-articles/2021/11/chmp-recommends-11-new-medicines-for-authorization
https://www.forbes.com/sites/siladityaray/2021/11/11/remdesivir-linked-covid-19-mutation-found-in-immunocompromised-patient-researchers-find/?sh=46470a8c125e
https://api.drreddys.com/news/dr-reddys-api-team-2021-winner-api-supplier-year-global-generics-biosimilars-awards
https://api.drreddys.com/news/dr-reddys-api-team-2021-winner-api-supplier-year-global-generics-biosimilars-awards
http://www.pmlive.com/pharma_news/gilead_sales_rise_by_13,_buoyed_by_anti-covid-19_drug_veklury_1382810
https://www.biopharmadive.com/news/gilead-veklury-coronavirus-earnings-oncology-outlook/609160/
https://www.businesswire.com/news/home/20211019005415/en/Gilead-Sciences-Announces-Veklury%C2%AE-Donations-to-Help-Address-the-Ongoing-COVID-19-Crisis-in-Indonesia-and-Armenia
https://www.reuters.com/world/us/merck-applies-us-emergency-authorization-covid-19-pill-2021-10-11/
Market Place
Share 
